SCHEMBL219327

SCHEMBL219327

CN(C)CCCCCC(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 12/20 0.68
KDM4C Q9H3R0 12/20 0.68
KDM5A P29375 1/20 0.68
KDM7A Q6ZMT4 1/20 0.68
PHF8 Q9UPP1 1/20 0.68
KDM2A Q9Y2K7 1/20 0.68
TSHR P16473 4/20 0.60
LMNA P02545 2/20 0.60
NFKB1 P19838 1/20 0.60
PMP22 Q01453 1/20 0.60
ALDH1A1 P00352 2/20 0.55
PPARG P37231 3/20 0.54
PPARD Q03181 3/20 0.54
PPARA Q07869 3/20 0.54
GPR84 Q9NQS5 2/20 0.54
HDAC11 Q96DB2 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
SLC22A6 Q4U2R8 1/20 0.54
SLC22A8 Q8TCC7 1/20 0.54
TLR2 O60603 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1176587 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL13286331 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL5530872 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL28020165 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL3402761 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL5219324 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL8213501 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL6029256 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
Water SCHEMBL11318112 0.98 KDM4A (0.66) KDM4AKDM4CKDM5AKDM7APHF8
Hydrochloric Acid SCHEMBL247487 0.98 KDM4A (0.69) KDM4AKDM4CKDM5AKDM7APHF8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727581-A2 PHARMACEUTICAL COMPOSITIONS FOR TARGETED DELIVERY OF BIOACTIVE AGENTS WITH IMPROVED BIOAVAILABILITY AND METHODS OF USE Shapiro, Scott (US) 2026-04-22 EP claimed
US-12466846-B2 Siloxane derivatives of amino acids having surface-active properties ADVANSIX RESINS & CHEMICALS LLC (US) 2025-11-11 US claimed
US-20250057955-A1 SURFACTANTS FOR USE IN HEALTHCARE PRODUCTS ADVANSIX RESINS & CHEMICALS LLC (US) 2025-02-20 US claimed
US-20250059395-A1 SURFACTANTS FOR INKS, PAINTS, AND ADHESIVES ADVANSIX RESINS & CHEMICALS LLC (US) 2025-02-20 US claimed
US-20250051686-A1 SURFACTANTS FOR CLEANING PRODUCTS ADVANSIX RESINS & CHEMICALS LLC (US) 2025-02-13 US claimed
WO-2025034837-A1 SURFACTANTS FOR USE IN HEALTHCARE PRODUCTS ADVANSIX RESINS & CHEMICALS LLC (US) 2025-02-13 WO claimed
WO-2025034827-A1 SURFACTANTS FOR USE IN AGRICULTURAL FORMULATIONS ADVANSIX RESINS & CHEMICALS LLC (US) 2025-02-13 WO claimed
US-20250049025-A1 SURFACTANTS FOR USE IN AGRICULTURAL FORMULATIONS ADVANSIX RESINS & CHEMICALS LLC (US) 2025-02-13 US claimed
WO-2025034841-A1 SURFACTANTS FOR ELECTRONICS ADVANSIX RESINS & CHEMICALS LLC (US) 2025-02-13 WO claimed
WO-2025034828-A1 SILOXANE DERIVATIVES OF AMINO ACIDS AS SURFACTANT IN PERSONAL CARE AND COSMETIC PRODUCTS ADVANSIX RESINS & CHEMICALS LLC (US) 2025-02-13 WO claimed
WO-2024044728-A1 PEGYLATED LIPID COMPOUNDS AND METHODS OF USE THEREOF RENAGADE THERAPEUTICS MANAGEMENT INC. (US) 2024-02-29 WO claimed
WO-2023163986-A1 SILOXANE DERIVATIVES OF AMINO ACIDS HAVING SURFACE-ACTIVE PROPERTIES ADVANSIX RESINS & CHEMICALS LLC (US) 2023-08-31 WO claimed
US-20230265112-A1 SILOXANE DERIVATIVES OF AMINO ACIDS HAVING SURFACE-ACTIVE PROPERTIES ADVANSIX RESINS & CHEMICALS LLC (US) 2023-08-24 US claimed
EP-4118174-A1 SURFACTANTS FOR CLEANING PRODUCTS AdvanSix Resins & Chemicals LLC (US) 2023-01-18 EP claimed
WO-2021183557-A1 SURFACTANTS FOR CLEANING PRODUCTS ADVANSIX RESINS & CHEMICALS LLC (US) 2021-09-16 WO claimed
CN-112321490-A Auxiliary agent and preparation method thereof 宿迁联盛科技股份有限公司 2021-02-05 CN claimed
EP-2961435-A2 CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS ImmunoGen, Inc. (US) 2016-01-06 EP claimed
WO-2014134486-A2 CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS IMMUNOGEN, INC. (US) 2014-09-04 WO claimed
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US claimed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250049025-A1 SURFACTANTS FOR USE IN AGRICULTURAL FORMULATIONS STOM, SRM, PTMS KDM4A 949/4885KDM4C 1337/4885KDM5A 1025/4885
US-20230265112-A1 SILOXANE DERIVATIVES OF AMINO ACIDS HAVING SURFACE-ACTIVE PROPERTIES BCAT1, PCMT1, LTN1 KDM4A 372/4885KDM4C 1267/4885KDM5A 999/4885
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES HSP90B1, HSP90AB1, HSP90AA1 KDM4A 3739/4885KDM4C 4034/4885KDM5A 4104/4885
US-20250051686-A1 SURFACTANTS FOR CLEANING PRODUCTS DAGLA, DSG1, DEGS1 KDM4A 1776/4885KDM4C 1605/4885KDM5A 1752/4885
US-20250059395-A1 SURFACTANTS FOR INKS, PAINTS, AND ADHESIVES ILK, VCL, ICAM1 KDM4A 1716/4885KDM4C 2017/4885KDM5A 1375/4885
US-12466846-B2 Siloxane derivatives of amino acids having surface-active properties BCAT1, PCMT1, LTN1 KDM4A 372/4885KDM4C 1267/4885KDM5A 999/4885
US-20250057955-A1 SURFACTANTS FOR USE IN HEALTHCARE PRODUCTS S100P, DSG1, TMSB10 KDM4A 3745/4885KDM4C 3347/4885KDM5A 1936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.